|
|
Vol. 25.23 – 29 July, 2024
|
|
|
|
|
|
|
|
Scientists found that CAR T cells exposed to myeloid leukemia showed impaired activation and cytolytic function, accompanied by impaired antigen receptor downstream calcium, ZAP70, ERK, and C-JUN signaling, compared to those exposed to B cell leukemia. [Nature Communications]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
A genetically encoded microbial activation strategy was reported that used tunable and dynamic expression of surface extracellular polysaccharides to improve bacterial biocompatibility while retaining therapeutic efficacy.
[Advanced Science]
|
|
|
|
|
|
The authors used interfacial self-assembly to prepare lipid membrane-coated bacteria, exhibiting increased resistance against a variety of harsh environmental conditions owing to the nanocoating’s protective capability.
[Nature Protocols]
|
|
|
|
|
|
Researchers showed that LNP-mRNA engineered dendritic cells could vaccinate recipient mice. Vaccinated mice showed strong anti-tumor T cell responses, rejected tumor challenge, and displayed no evidence of toxicity.
[Small Methods]
|
|
|
|
|
|
The authors showed that proton radiation therapy increased mesothelin expression, modulated the immunosuppressive microenvironment, and improved the antitumor response of CAR T therapy, underscoring the transformative potential of this strategy.
[Proceedings of The National Academy of Sciences of The United States of America]
|
|
|
|
|
|
CAR-T cells targeting GPC2, GPC3, and MSLN were used in combination with NT-I7 to assess the anticancer activity.
[Journal For Immunotherapy of Cancer]
|
|
|
|
|
|
Scientists reported that IFNγ, a potent immunomodulator secreted in the tumor microenvironment, could induce α2,6 hypersialylation in cancer cell lines derived from various histologies.
[Cancer Immunology Research]
|
|
|
|
|
|
The authors developed chimeric adaptor proteins and CAR tyrosine kinases in which the intracellular ζ T cell receptor (TCRζ) chain was replaced with intracellular protein domains to stimulate signaling downstream of the TCRζ chain.
[Science Signaling]
|
|
|
|
|
|
Researchers experimentally studied whether impulse generation by transplanted cardiomyocytes could propagate to the host myocardium and overdrive the recipient rhythm. [Stem Cell Reports]
|
|
|
|
|
|
|
|
|
The authors discuss key advances and challenges in the clinical translation of hypoimmunogenic cells and describe the genetic engineering methods and manufacturing processes used to create hypoimmunogenic therapeutic cells, while highlighting the complexity of relevant immunological pathways.
[Nature Reviews Bioengineering]
|
|
|
|
|
|
For major alpha thalassemia and severe osteogenesis imperfecta, in utero stem cell transplantation has entered the Phase I clinical trial stage. [Advanced Biology]
|
|
|
|
|
|
|
|
Anixa Biosciences, Inc. announced that its collaborator, Moffitt Cancer Center (Moffitt), has received approval by the FDA of an individual patient Investigational New Drug Application to allow a second dose of its CAR-T therapy for a patient that may be demonstrating clinical activity to the initial treatment.
[Targeted Oncology]
|
|
|
|
|
|
Retraction notices — the explanatory statements published alongside papers that have been withdrawn from the literature — have become more clearly worded and easier to access in some cases, according to a study that looked at hundreds of these notices. [Nature]
|
|
|
|
|
|
|
|
September 1 – 4, 2024 Dublin, Ireland
|
|
|
|
|
|
|
|
|
|
|
The Cambridge Stem Cell Institute – Cambridge, England, United Kingdom
|
|
|
|
|
|
|
The University of Edinburgh – Edinburgh, Scotland, United Kingdom
|
|
|
|
|
|
|
Max Planck Institute – Planegg, Germany
|
|
|
|
|
|
|
ElevateBio – Waltham, Massachusetts, United States
|
|
|
|
|
|
|
University of British Columbia – Vancouver, British Columbia, Canada
|
|
|
|
|
|